首页> Clinical cancer research : an official journal of the American Association for Cancer Research> The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.

The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.

导出 OA

翻译打印收藏纠错

第一作者： Adrienne G,Waks

第一单位： Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

作者： Adrienne G,Waks ^[1] ; Daniel G,Stover ^[2] ; Jennifer L,Guerriero ^[3] ; Deborah,Dillon ^[4] ; William T,Barry ^[5] ; Evisa,Gjini ^[4] ; Christina,Hartl ^[3] ; Wesley,Lo ^[6] ; Jennifer,Savoie ^[1] ; Jane,Brock ^[4] ; Robert,Wesolowski ^[2] ; Zaibo,Li ^[7] ; Adrienne,Damicis ^[8] ; Anne V,Philips ^[9] ; Yun,Wu ^[10] ; Fei,Yang ^[11] ; Amy,Sullivan ^[12] ; Patrick,Danaher ^[12] ; Heather Ann,Brauer ^[12] ; Wafa,Osmani ^[1] ; Mikel,Lipschitz ^[4] ; Katherine A,Hoadley ^[13] ; Michael,Goldberg ^[6] ; Charles M,Perou ^[13] ; Scott,Rodig ^[4] ; Eric P,Winer ^[1] ; Ian E,Krop ^[1] ; Elizabeth A,Mittendorf ^[14] ; Sara M,Tolaney ^[15]

作者单位： Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[1] Division of Medical Oncology, Ohio State University College of Medicine, Columbus, Ohio. ^[2] Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[3] Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. ^[4] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[5] Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[6] Department of Pathology, Ohio State University College of Medicine, Columbus, Ohio. ^[7] Department of Biostatistics, Ohio State University College of Public Health, Columbus, Ohio. ^[8] Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[9] Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[10] Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[11] NanoString Technologies, Seattle, Washington. ^[12] University of North Carolina School of Medicine, Chapel Hill, North Carolina. ^[13] Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.;Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts. ^[14] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. sara_tolaney@dfci.harvard.edu. ^[15]